Logo del repository
  1. Home
 
Opzioni

Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?

Cappelletti, Maria Rosa
•
Gnetti, Letizia
•
Santini, Daniele
altro
GENERALI, DANIELE
2015
  • journal article

Periodico
ONCOSCIENCE
Abstract
N/A
DOI
10.18632/oncoscience.168
Archivio
http://hdl.handle.net/11368/2903837
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84958544242
http://www.impactjournals.com/oncoscience/index.php?pii=168
Diritti
open access
license:creative commons
license uri:http://creativecommons.org/licenses/by/3.0/it/
FVG url
https://arts.units.it/bitstream/11368/2903837/2/Combination_of_everolimus.pdf
Soggetti
  • Endometrial cancer

  • Everolimu

  • FGFR inhibitor

  • FGFR2

  • Cancer Research

  • Oncology

Scopus© citazioni
1
Data di acquisizione
Jun 7, 2022
Vedi dettagli
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback